What is Invaio Sciences?
Invaio Sciences is a multi-platform technology company founded in 2018 by Flagship Pioneering. It aims to unlock the potential of interdependent systems to address critical global issues in agriculture, nutrition, and the environment. By integrating discoveries from human therapeutics, agriculture, environmental science, and advanced manufacturing, Invaio Sciences develops novel solutions that target insect and plant physiology. The company's approach seeks to refine agricultural practices and reduce the global reliance on pesticides, with a focus on creating products that are safe for beneficial insects, detrimental to pests, and ultimately safer for human consumption and the environment. The company's deep scientific understanding and integrated solutions strategy position it as a key player in sustainable agriculture.
How much funding has Invaio Sciences raised?
Invaio Sciences has raised a total of $138.9M across 2 funding rounds:
Series C
$88.9M
Debt
$50M
Series C (2021): $88.9M with participation from Bluwave Capital, Stage 1 Ventures, and Alexandria Venture Investments
Debt (2021): $50M led by K2 HealthVentures
Key Investors in Invaio Sciences
K2 HealthVentures
K2 HealthVentures is an alternative investment firm focused on providing flexible, long-term financing solutions to innovative private and public companies in the life sciences and healthcare industries. Their investment team possesses deep domain knowledge and a flexible capital structure to meet evolving capital needs.
Stage 1 Ventures
Stage 1 Ventures is a venture capital firm that invests in early-stage companies transforming global industries through disruptive deep tech and science. They provide access to resources, market insights, and a collaborative network to help startups scale.
Alexandria Venture Investments
Alexandria Venture Investments is an investment entity that supports companies within the life sciences and technology sectors, likely focusing on ventures with significant growth potential and innovative approaches.
What's next for Invaio Sciences?
The substantial enterprise-level funding and recent strategic investment indicate Invaio Sciences is poised for significant scaling and further research and development. This capital infusion will likely accelerate the company's mission to refine agricultural practices and reduce pesticide use globally. Future endeavors may include expanding its technological platforms, forging new strategic partnerships, and broadening its market reach to implement its sustainable solutions across diverse agricultural landscapes. The company's focus on beneficial insects and environmental safety suggests a continued commitment to developing products that align with global sustainability goals.
See full Invaio Sciences company page
